Comparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea-Reference-Cited by-同舟云学术

Comparing the effectiveness of bivalent and monovalent COVID-19 vaccines against COVID-19 infection during the winter season of 2022-2023: A real-world retrospective observational matched cohort study in the Republic of Korea

Published:2023-10 Issue: Volume:135 Page:95-100
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Chae Chungman^ORCID,Kim Ryu Kyung^ORCID,Jang Eun Jung,Shim Ji Ae,Park Eunkyung^ORCID,Lee Kil Hun^ORCID,Hong Sye Lim,Aziz Asma Binte,Tadesse Birkneh Tilahun^ORCID,Marks Florian,Tak Sangwoo,Lee Sangwon,Kwon Donghyok

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference16 articles.

1. Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study;Arbel;Lancet Infect Dis,2023

2. Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan;Arashiro;Open Forum Infect Dis,2023

3. Approval for emergency use of a bivalent vaccine against the Pfizer Omicron mutation (BA.4/5),2022

4. Permission to import the Pfizer bivalent vaccine against Omicron mutations (BA.1) [press release],2022

5. The Ministry of Food and Drug Safety approved a modern bivalent vaccine against Omicron mutations (BA.1),2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative safety of monovalent and bivalent mRNA COVID-19 booster vaccines in adolescents aged 12 to 17 years in the Republic of Korea;Osong Public Health and Research Perspectives;2024-08-31

2. Prioritization of Vaccines for Introduction in the National Immunization Program in the Republic of Korea;Vaccines;2024-08-04

3. A systematic review and meta-analysis on the effectiveness of bivalent mRNA booster vaccines against Omicron variants;Vaccine;2024-05

4. Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis;Frontiers in Medicine;2024-02-07

5. Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales;The Lancet Regional Health - Europe;2024-02